Maryland Senate Bill 1007 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 5 2018 - 25% progression, died in chamber
Action: 2018-03-16 - Unfavorable Report by Finance; Withdrawn
Text: Latest bill text (Introduced) [PDF]

Requiring the Prescription Drug Monitoring Program to disclose prescription drug monitoring data, in accordance with certain regulations, on the approval of the Secretary of Health, to the Attorney General for the purpose of law enforcement; requiring, rather than authorizing, the Program to make a certain notification and provide certain education to a certain prescriber or dispenser; requiring that the notification be made and the education be provided within a certain period of time; etc.

Prescription Drug Monitoring Program – Opioid Data – Disclosure

Sen. Paul Pinsky [D]

Date	Chamber	Action
2018-03-16	Senate	Unfavorable Report by Finance; Withdrawn
2018-03-15	Senate	Hearing canceled
2018-03-15	Senate	Hearing 3/15 at 1:00 p.m.
2018-02-05	Senate	First Reading Finance

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB1007?ys=2018rs
Text	https://mgaleg.maryland.gov/2018RS/bills/sb/sb1007f.pdf
Supplement	https://mgaleg.maryland.gov/2018RS/fnotes/bil_0007/sb1007.pdf
Supplement	https://mgaleg.maryland.gov/2018RS/votes_comm/sb1007_fin.pdf